β³ Fetching live dividend data...
Home βΊ Calculator βΊ SGMO Dividend Calculator 2026
Sangamo Therapeutics, Inc. Β· PNK
Price: $0.07 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SGMO β $7.590802824009443e+25M in 10 years Β· $6,325,440,464,053,602,000,000,000,000,000.00/month
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for chronic neuropathic pain, and prion disease; Phase 1/2 clinical trial to evaluate the safety and tolerability of the investigational genetically modified cell therapy TX200 in patients undergoing a kidney transplant.; SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A; giroctocogene fitelparvovec, a Phase 3 study to evaluate the clinical efficacy and safety of giroctocogene fitelparvovec gene therapy in adult male with moderately severe or severe hemophilia A. Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Genentech, Inc.; Astellas Gene Therapies, Inc.; Capsid Delivery License Agreement with Eli Lilly and Company; Alexion Pharmaceuticals, Inc. Β ALS and Frontotemporal Lobar Degeneration; Takeda Β Huntington's Disease; and other areas, such as plant agriculture and research reagents, including the production of transgenic animals and cell-line engineering with Corteva AgriScience and Open Monoclonal Technology, Inc. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. The company was incorporated in 1995 and is headquartered in Richmond, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open SGMO position with:
Real after-tax yield depends on where you live and how you hold SGMO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 2702.70% | 2699.90% | $270,270 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 2297.29% | 2294.49% | $229,729 / yr |
| πΊπΈ US Taxable (20%) | 20% | 2162.16% | 2159.36% | $216,216 / yr |
| π¬π§ UK ISA | 0% | 2702.70% | 2699.90% | $270,270 / yr |
| π¬π§ UK Taxable | 8.75% | 2466.21% | 2463.41% | $246,621 / yr |
| π¨π¦ TFSA | 0% | 2702.70% | 2699.90% | $270,270 / yr |
| π¨π¦ CA Taxable | 25% | 2027.02% | 2024.22% | $202,702 / yr |
| π¦πΊ Super (pension) | 15% | 2297.29% | 2294.49% | $229,729 / yr |
| π¦πΊ AU Taxable | 30% | 1891.89% | 1889.09% | $189,189 / yr |
| π©πͺ DE Taxable | 26.375% | 1989.86% | 1987.06% | $198,986 / yr |
| π«π· FR Taxable | 30% | 1891.89% | 1889.09% | $189,189 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
SGMO pays quarterly β 4 times per year. Next ex-div: TBD.
How SGMO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SGMO sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-05-25 | 1,630 | $0.17 | $284.00 | ||
| F-InKind | 2026-05-25 | 1,919 | $0.17 | $334.00 | ||
| F-InKind | 2026-05-25 | 4,036 | $0.17 | $703.00 | ||
| F-InKind | 2026-05-25 | 4,036 | $0.17 | $703.00 | ||
| F-InKind | 2026-05-25 | 12,613 | $0.17 | $2.2K | ||
| Sale | 2026-04-22 | 69,827 | $0.25 | $17.7K | ||
| Sale | 2026-04-21 | 345,942 | $0.26 | $89.2K | ||
| A-Award | 2026-04-01 | 800,000 | $0.26 | $208.1K | ||
| A-Award | 2026-04-01 | 225,000 | $0.26 | $58.5K | ||
| A-Award | 2026-04-01 | 225,000 | $0.26 | $58.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SGMO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Sangamo Therapeutics, Inc. (SGMO) is currently trading at $0.07, trading near its 52-week low. The current dividend yield is 2702.70% based on an annual payout of $2.00 per share.
Sangamo Therapeutics, Inc. (SGMO) is a healthcare stock currently trading at $0.07 with a dividend yield of 2702.70%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β